The government on Thursday approved an additional Rs45 billion budget for the armed forces mainly to strengthen their capacity to protect Chinese commercial interests in Pakistan and manage the ...

But surely one of the main highlights of the iPhone SE 4 will be Apple’s first 5G modem. The company acquired Intel’s modem division in 2019 in an attempt to dispose of Qualcomm’s modems ...

To maintain the extensive network of cables and develop new ones, private cable companies have for decades relied on being able to move freely through this waterway, despite conflicting claims ...

Last year, Charter Spectrum and Disney were engaged in a high-profile carriage dispute, with the cable company demanding “a new model” for how it sells TV by including streaming services with ...

The cable company already offers access to Disney (DIS)+, ESPN+, Paramount (PARA)+, AMC (AMCX)+, BET+, ViX, Max (WBD), and Discovery+ to its Spectrum TV Select video customers. The deal comes as ...

"As the drug has already been approved, it doesn't have to undergo a complex approval procedure and could soon supplement the standard therapy for this deadly brain tumor." A noninvasive treatment ...

It appears this owner didn’t purchase the Nissan-approved cable. While this may have saved them some money upfront, it appears to have cost them more in the long run. While EV battery fires can have ...

President Joe Biden on Sunday said the US will send Taiwan its largest-ever security package amid rising tensions with China. The $567 million in aid will be used for "defense articles and ...

Some still remain unconfirmed as of the writing of this article. Whatever maybe the case, the list of major musicians and bands going on tour is too big for any one person to keep track solely by ...

President Joe Biden on Sunday approved $567 million in defense aid for Taiwan. It is the largest aid package that US has ever sent to Taiwan. China responded, stating the move violates the one-China ...

Otulfi was approved simultaneously in the European Union. In the US, it will launch in February 2025. The FDA has approved the fourth ustekinumab biosimilar, ustekinumab-aauz (Otulfi) from Formycon ...